Patent Assignment
Reel/Frame 065943/0742
Security Interest
Recorded: 2023-12-22
Pages: 7
Assignor
ACERUS PHARMACEUTICALS CORPORATION
Executed: 2023-12-21
Assignee
FIRST GENERATION CAPITAL INC.
40 KING STREET WEST, TORONTO, ONTARIO, M5H 3Y, CANADA
Covered Properties
(3)
Intranasal 0.45% and 0.48% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder
Application:
14/922,015 →
Publication:
US 2016/0250228
Nasal Cannabidiol Compositions
Application:
15/613,116 →
Publication:
US 2017/0348276
Neurosteroid Derivatives and Uses Thereof
Application:
16/403,100 →
Publication:
US 2019/0337975
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 27, 2017
From: BRYSON, NATHAN; SHARMA, AVINASH
To: ACERUS PHARMACEUTICALS CORPORATION
Reel/Frame 042822/0764 →
Security Interest
Jan 24, 2018
From: ACERUS LABS INC.
To: QUANTIUS INC.
Reel/Frame 044719/0876 →
Assignment of Assignor's Interest
Mar 8, 2018
From: ACERUS PHARMACEUTICALS CORPORATION
To: ACERUS LABS. INC.
Reel/Frame 045141/0849 →
Intellectual Property Security Agreement
Oct 11, 2018
From: ACERUS PHARMACEUTICALS CORPORATION; ACERUS BIOPHARMA INC.; ACERUS LABS INC.
To: SWK FUNDING LLC
Reel/Frame 047217/0760 →
Release of Security Interest
Nov 2, 2018
From: QUANTIUS INC.
To: ACERUS PHARMACEUTICALS CORPORATION; ACERUS LABS INC.; ACERUS BIOPHARMA INC.
Reel/Frame 047399/0698 →
Assignment of Assignor's Interest
Jun 18, 2019
From: BRYSON, NATHAN; SHARMA, AVINASH CHANDER
To: ACERUS PHARMACEUTICALS CORPORATION
Reel/Frame 049508/0223 →